A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
MOMA Therapeutics
Kestrel Therapeutics, Inc.
Mersana Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Context Therapeutics Inc.
Regor Pharmaceuticals Inc.
OncoC4, Inc.
Compass Therapeutics
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
Fate Therapeutics
Epsilogen Ltd
Boehringer Ingelheim
IDEAYA Biosciences
Agenus Inc.
Radiopharm Theranostics, Ltd
Cogent Biosciences, Inc.
Whitehawk Therapeutics, Inc.
GlaxoSmithKline
SystImmune Inc.
Institut Paoli-Calmettes
Eli Lilly and Company
Xencor, Inc.
Atavistik Bio, Inc
Eli Lilly and Company
Whitehawk Therapeutics, Inc.
NiKang Therapeutics, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
Alterome Therapeutics, Inc.
BeOne Medicines
Sutro Biopharma, Inc.
Eli Lilly and Company
University of Miami
Accent Therapeutics
Seagen Inc.
AbbVie
Myeloid Therapeutics
Tizona Therapeutics, Inc
SEED Therapeutics, Inc.
Dana-Farber Cancer Institute
TORL Biotherapeutics, LLC
Normunity AccelCo, Inc.